Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?
- 12 August 2008
- journal article
- review article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 179 (4) , 333-337
- https://doi.org/10.1503/cmaj.071131
Abstract
Anemia of chronic disease is a hypoproliferative anemia that develops in response to systemic illness or inflammation.[1][1] It was first described in the 1930s and was more fully characterized by Cartwright and Wintrobe in the 1950s.[2][2] Although the second most prevalent after anemia caused byThis publication has 45 references indexed in Scilit:
- Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trialsCMAJ : Canadian Medical Association Journal, 2007
- Efficacy and Safety of Epoetin Alfa in Critically Ill PatientsNew England Journal of Medicine, 2007
- Maintaining Normal Hemoglobin Levels With Epoetin Alfa in Mainly Nonanemic Patients With Metastatic Breast Cancer Receiving First-Line Chemotherapy: A Survival StudyJournal of Clinical Oncology, 2005
- Physiologic aspects of anemiaCritical Care Clinics, 2004
- The CRIT Study: Anemia and blood transfusion in the critically ill—Current clinical practice in the United States*Critical Care Medicine, 2004
- Tolerance to Acute Isovolemic HemodilutionAnesthesiology, 2003
- Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.2001
- Prognostic evaluation of primary non-small cell lung carcinoma patients using biological fluid variables. A systematic reviewScandinavian Journal of Clinical and Laboratory Investigation, 2000
- Intravenous Iron and Erythropoietin for Anemia Associated with Crohn DiseaseAnnals of Internal Medicine, 1997
- THE CARDIAC OUTPUT IN PATIENTS WITH CHRONIC ANEMIA AS MEASURED BY THE TECHNIQUE OF RIGHT ATRIAL CATHETERIZATION 1Journal of Clinical Investigation, 1945